Latest filing published 24 Mar 2008 for CASI Pharmaceuticals, Inc., €1,282.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -29.0%Entry 75.90 · Close at T+365 53.90
- -72.5%Entry 75.90 · Close at T+365 20.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Dane R. Saglio: trading record in brief
Dane R. Saglio appears in our data through filings on CASI Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 19 March 2008 to 20 March 2008.
Every open-market trade on record is a purchase: 2 purchases worth €2,050, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 24 March 2008, the filings show an open-market purchase worth €1,282 in CASI Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dane R. Saglio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$0.66Common StockSEC:0001209191-08-019789:0Canonical exit: 18 Jun 2008 (T+90)
- 2,000 shares@ US$0.60Common StockSEC:0001209191-08-019364:0Canonical exit: 17 Jun 2008 (T+90)
2 of 2 declarations